These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 16033478

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Cutaneous side effects of EGFR inhibitors--appearance and management].
    Wollenberg A, Kroth J, Hauschild A, Dirschka T.
    Dtsch Med Wochenschr; 2010 Jan; 135(4):149-54. PubMed ID: 20101558
    [Abstract] [Full Text] [Related]

  • 3. [Cutaneous side effects of EGF-receptor inhibition and their management].
    Gutzmer R, Werfel T, Kapp A, Elsner J.
    Hautarzt; 2006 Jun; 57(6):509-13. PubMed ID: 16205868
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical presentation and pathophysiology of EGFRI dermatologic toxicities.
    Mitchell EP, Perez-Soler R, Van Cutsem E, Lacouture ME.
    Oncology (Williston Park); 2007 Oct; 21(11 Suppl 5):4-9. PubMed ID: 18154212
    [Abstract] [Full Text] [Related]

  • 6. An interdisciplinary consensus on managing skin reactions associated with human epidermal growth factor receptor inhibitors.
    Eaby B, Culkin A, Lacouture ME.
    Clin J Oncol Nurs; 2008 Apr; 12(2):283-90. PubMed ID: 18390464
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Cutaneous side effects of EGF receptor inhibitors].
    Nassar D, Soutou B, Aractingi S.
    Bull Cancer; 2009 Dec; 96 Suppl():S85-91. PubMed ID: 20034874
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Management of cutaneous side-effects of cetuximab therapy in patients with metastatic colorectal cancer.
    Ocvirk J, Cencelj S.
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):453-9. PubMed ID: 19793151
    [Abstract] [Full Text] [Related]

  • 12. Cutaneous adverse effects during therapy with an epidermal growth factor receptor (EGFR) inhibitor.
    Santoro F, Cozzani E, Parodi A.
    J Dermatolog Treat; 2006 Apr; 17(3):160-1. PubMed ID: 16854757
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Trichomegaly of the eyelashes during therapy with epidermal growth factor receptor inhibitors: report of 3 cases.
    Fabbrocini G, Panariello L, Cacciapuoti S, Bianca D, Ayala F.
    Dermatitis; 2012 Apr; 23(5):237-8. PubMed ID: 23010833
    [Abstract] [Full Text] [Related]

  • 16. Papulopustular drug eruption due to an epidermal growth factor receptor inhibitors, erlotinib and cetuximab.
    Bragg J, Pomeranz MK.
    Dermatol Online J; 2007 Jan 27; 13(1):1. PubMed ID: 17511934
    [Abstract] [Full Text] [Related]

  • 17. Description and management of cutaneous side effects during cetuximab or erlotinib treatments: a prospective study of 30 patients.
    Roé E, García Muret MP, Marcuello E, Capdevila J, Pallarés C, Alomar A.
    J Am Acad Dermatol; 2006 Sep 27; 55(3):429-37. PubMed ID: 16908348
    [Abstract] [Full Text] [Related]

  • 18. Adverse cutaneous reactions to epidermal growth factor receptor inhibitors: a study of 14 patients.
    Santiago F, Gonçalo M, Reis JP, Figueiredo A.
    An Bras Dermatol; 2011 Sep 27; 86(3):483-90. PubMed ID: 21738965
    [Abstract] [Full Text] [Related]

  • 19. Chemotherapeutic agents and the skin: An update.
    Heidary N, Naik H, Burgin S.
    J Am Acad Dermatol; 2008 Apr 27; 58(4):545-70. PubMed ID: 18342708
    [Abstract] [Full Text] [Related]

  • 20. Severe acneiform skin reaction during therapy with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor.
    Eames T, Landthaler M, Karrer S.
    Eur J Dermatol; 2007 Apr 27; 17(6):552-3. PubMed ID: 17951151
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.